C-reactive protein and reactive oxygen metabolites in subjects with metabolic syndrome

Journal of International Medical Research

Volumn 40, Issue 3, 2012, Pages 1074-1081

  Kotani, Kazuhiko ^a,b   Sakane, N ^a  

^a NATIONAL HOSPITAL ORGANIZATION   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; C reactive protein; Derivatives of reactive oxygen metabolites; Inflammation; Metabolic syndrome; Oxidative stress; Oxygen reactive species

Indexed keywords

C REACTIVE PROTEIN; DIACRON REACTIVE OXYGEN METABOLITE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOMETABOLIC RISK; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE PREDISPOSITION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OBSERVATIONAL STUDY; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84863104027     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001204000326     Document Type: Article

References (29)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
2. Bruce KD, Byrne CD: The metabolic syndrome: common origins of a multifactorial disorder. Postgrad Med J 2009; 85: 614-621.
3. Huang AL, Vita JA: Effects of systemic inflammation on endothelium-dependent vasodilation. Trends Cardiovasc Med 2006; 16: 15-20.
4. Navab M, Gharavi N, Watson AD: Inflammation and metabolic disorders. Curr Opin Clin Nutr Metab Care 2008; 11: 459-464.
5. Higashi Y, Noma K, Yoshizumi M, et al: Endothelial function and oxidative stress in cardiovascular diseases. Circ J 2009; 73: 411-418.
6. Zambon A, Pauletto P, Crepaldi G: Review article: the metabolic syndrome-a chronic cardiovascular inflammatory condition. Aliment Pharmacol Ther 2005; 22(suppl 2): 20-23.
7. Van Guilder GP, Hoetzer GL, Greiner JJ, et al: Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults. Obesity 2006; 14: 2127-2131.
8. Seet RC, Lee CY, Lim EC, et al: Markers of oxidative damage are not elevated in otherwise healthy individuals with the metabolic syndrome. Diabetes Care 2010; 33: 1140-1142.
9. Stephens JW, Khanolkar MP, Bain SC: The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis 2009; 202: 321-329.
10. Alberti A, Bolognini L, Macciantelli D, et al: The radical cation of N, N-diethyl-paraphenylendiamine: a possible indicator of oxidative stress in biological samples. Research on Chemical Intermediates 2000; 26: 253-267.
11. Iamele L, Fiocchi R, Vernocchi A: Evaluation of an automated spectrophotometric assay for reactive oxygen metabolites in serum. Clin Chem Lab Med 2002; 40: 673-676.
12. Vassalle C: An easy and reliable automated method to estimate oxidative stress in the clinical setting. Methods Mol Biol 2008; 477: 31-39.
13. Kamezaki F, Yamashita K, Kubara T, et al: Derivatives of reactive oxygen metabolites correlates with high-sensitivity C-reactive protein. J Atheroscler Thromb 2008; 15: 206-212.
14. Sakane N, Fujiwara S, Sano Y, et al: Oxidative stress, inflammation, and atherosclerotic changes in retinal arteries in the Japanese population; results from the Mima study. Endocr J 2008; 55: 485-488.
15. Hirose H, Kawabe H, Komiya N, et al: Relations between serum reactive oxygen metabolites (ROMs) and various inflammatory and metabolic parameters in a Japanese population. J Atheroscler Thromb 2009; 16: 77-82.
16. Sugiura T, Dohi Y, Takase H, et al: Increased reactive oxygen metabolites is associated with cardiovascular risk factors and vascular endothelial damage in middle-aged Japanese subjects. Vasc Health Risk Manag 2011; 7: 475-482.
17. Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study of Obesity: New criteria for 'obesity disease' in Japan. Circ J 2002; 66: 987-992.
18. Vincent HK, Taylor AG: Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes 2006; 30: 400-418.
19. Furukawa S, Fujita T, Shimabukuro M, et al: Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752-1761.
20. Bastard JP, Maachi M, Lagathu C, et al: Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006; 17: 4-12.
21. Galic S, Oakhill JS, Steinberg GR: Adipose tissue as an endocrine organ. Mol Cell Endocrinol 2010; 316: 129-139.
22. Nakazono K, Watanabe N, Matsuno K, et al: Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci U S A 1991; 88: 10045-10048.
23. Meyers MR, Gokce N: Endothelial dysfunction in obesity: etiological role in atherosclerosis. Curr Opin Endocrinol Diabetes Obes 2007; 14: 365-369.
24. ε- (hexanoyl)lysine, and C-reactive protein in rabbit atherosclerotic lesions. J Atheroscler Thromb 2008; 15: 185-192.
25. Yasojima K, Schwab C, McGeer EG, et al: Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol 2001; 158: 1039-1051.
26. Kobayashi S, Inoue N, Ohashi Y, et al: Interaction of oxidative stress and inflammatory response in coronary plaque instability: important role of C-reactive protein. Arterioscler Thromb Vasc Biol 2003; 23: 1398-1404.
27. Devaraj S, Dasu MR, Singh U, et al: C-reactive protein stimulates superoxide anion release and tissue factor activity in vivo. Atherosclerosis 2009; 203: 67-74.
28. Vîrgolici B, Mohora M, Stoian I, et al: A comparative oxidative stress study-obesity with and without diabetes mellitus. Rom J Intern Med 2005; 43: 261-268.
29. Hoekstra T, Geleijnse JM, Schouten EG, et al: Relationship of C-reactive protein with components of the metabolic syndrome in normal-weight and overweight elderly. Nutr Metab Cardiovasc Dis 2005; 15: 270-278.